title: Effect of atherogenic diet on reverse cholesterol transport in vivo in atherosclerosis susceptible (C57BL/6) and resistant (C3H) mice.
abstract: Mice susceptible (C57BL/6) or resistant (C3H) to atherosclerosis induced by a high cholesterol-cholate containing diet (A-diet) were used to study reverse cholesterol transport (RCT) in vivo as measured by loss of cholesterol from a depot created by injection of cationized LDL into the rectus femoris muscle. Plasma total and HDL-cholesterol (HDL-C), total and HDL phospholipid (HDL-PL) levels in chow fed C3H male and female mice were higher than in C57BL/6 mice. After one month on A-diet, plasma cholesterol more than doubled in both strains and genders. The decrease in HDL-C and HDL-PL was twice as great in C57BL/6 as in C3H female mice, while in male C3H mice there was no decrease. The loss of exogenous cholesterol mass (ECM) after injection of cationized LDL was more rapid in C3H than in C57BL/6 mice. In chow fed mice, ECM retained in muscle on day 12 was 37% in C57BL/6 and 20% in C3H females; in males it was 39% and 18% in C57BL/6 and C3H, respectively. On A-diet, 76% were retained in C57BL/6 and 28% in C3H females; these values were 59% and 28% in C57BL/6 and C3H males. Thus, the slow clearance of ECM (which represents RCT) in C57BL/6 mice on A-diet, that could be related to a marked decrease of HDL-PL, might contribute towards their susceptibility to atherosclerosis.
authors.affiliation: Department of Experimental Medicine and Cancer Research, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
authors.forename: O
authors.initials: O
authors.lastname: Stein
authors.forename: Y
authors.initials: Y
authors.lastname: Dabach
authors.forename: G
authors.initials: G
authors.lastname: Hollander
authors.forename: M
authors.initials: M
authors.lastname: Ben-Naim
authors.forename: G
authors.initials: G
authors.lastname: Halperin
authors.forename: Y
authors.initials: Y
authors.lastname: Stein
mesh_terms: D000818:Animals; D001161:Arteriosclerosis / Q000178:diet therapy* / Q000378:metabolism*; D001693:Biological Transport, Active / Q000502:physiology; D002784:Cholesterol / Q000032:analysis / Q000378:metabolism*; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D008076:Cholesterol, HDL / Q000032:analysis / Q000097:blood*; D008078:Cholesterol, LDL / Q000032:analysis / Q000097:blood*; D004195:Disease Models, Animal; D005260:Female; D016014:Linear Models; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D011336:Probability; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D013045:Species Specificity
chemical_list: D002791:Cholesterol, Dietary; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D002784:Cholesterol